Rituximab/Bendamustine + Rituximab/Cytarabine for Mantle Cell Lymphoma
Clinical trial NCT01661881 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT01661881
- Sponsor
- Christine Ryan
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-08-16
- Primary completion
- 2015-02-01
- Enrollment
- 23
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.